in this issue
People & Business :: M&A
Hospira to Acquire API Facility in India for $200 Million
7:36 AM MDT | August 29, 2012 | Deepti Ramesh
Hospira (Lake Forest, IL), the world's leading provider of injectable drugs and infusion technologies, says it has signed an agreement to acquire an active pharmaceutical ingredient (API) manufacturing facility, together with an associated research and development (R&D) facility from Orchid Chemicals & Pharmaceuticals (Chennai, India), a leading Indian pharmaceutical company, for about $200 million. The API manufacturing facility is located at Aurangabad, India and it employs about 640 people, and the associated R&D facility is located at Chennai...
This information is only available to Chemical Week subscribers.
Forgot your user ID or password?
Not an IHS Chemical Week member yet?
Here's why you should be:
100% Satisfaction Guarantee